
|Articles|November 26, 2007
Alcon makes final push for WaveLight
Alcon has received all the required regulatory clearances relating to its tender offer for WaveLight AG.
Advertisement
Alcon has received all the required regulatory clearances relating to its tender offer for WaveLight AG.
Upon settlement of all tendered shares, Alcon will own 77.4% of the outstanding WaveLight shares and shareholders who tendered their shares under the offer will automatically receive payment.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
2
Oku Digital Health launches from Topcon to link eye care, primary care
3
EURETINA 2026: Optogenetic therapy MCO-010 aims to restore vision in advanced macular disease
4
Real-world VOYAGER data on faricimab in nAMD, DME, RVO at EURETINA 2026
5



















